This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Ben Kleinstiver, PhD
Associate Professor at Massachusetts General Hospital & Harvard Medical School
Speaker

Profile

Dr. Kleinstiver is an Associate Professor in the Center for Genomic Medicine and Department of Pathology at Massachusetts General Hospital and Harvard Medical School and is the Kayden-Lambert MGH Research Scholar. He is a biochemist by training and now runs a research lab focused on genome editing technology development seeking to optimize new methods to modify genetic sequences. Some of the major goals in the Kleinstiver lab are to develop safe effective and versatile tools that can correct genetic mutations that underlie human disease while solving challenges that can expand access of gene editing treatments to a wider base of patients.